Literature DB >> 30012871

Role of Mitochondrial Dysfunction and Reactive Oxygen Species in Mediating Hypertension in the Reduced Uterine Perfusion Pressure Rat Model of Preeclampsia.

Venkata Ramana Vaka1, Kristen M McMaster2, Mark W Cunningham1, Tarek Ibrahim1, Rebekah Hazlewood1, Nathan Usry1, Denise C Cornelius3, Lorena M Amaral1, Babbette LaMarca1,2.   

Abstract

Placental ischemia is believed to be the initial event in the development of preeclampsia. Mitochondrial dysfunction is a cause of reactive oxygen species (ROS) generation and oxidative stress, however, there are not many studies examining the role of mitochondrial ROS in the pathology of preeclampsia. The purpose of this study was to not only examine the effect of placental ischemia on mitochondrial-mediated oxidative stress in reduced uterine perfusion pressure (RUPP) rat model of preeclampsia but to also examine the role of mitochondrial ROS in contributing to hypertension in response to placental ischemia. Female pregnant Sprague Dawley rats were used in this study. On gestational day 14, RUPP surgery was performed. On gestational day 19, blood pressure (mean arterial pressure) was measured, placentas and kidneys were collected from normal pregnant and RUPP rats and processed for mitochondrial respiration, ROS, and oxidative phosphorylation enzyme activities. Renal and placental complex activities, expressions and respiration rates were significantly reduced and mitochondrial ROS was increased in RUPP versus normal pregnant mitochondria. Mean arterial pressure was elevated in RUPP (n=6) compared with normal pregnant rats (n=5; 126±4 versus 103±4 mm Hg; P<0.05) and treatment with mitochondrial-specific antioxidants (MitoQ/MitoTEMPO) significantly reduced mean arterial pressure in RUPPs (n=5-10). Mitochondrial ROS was significantly elevated in endothelial cells incubated with RUPP serum compared from with normal pregnant rats, whereas serum from mito antioxidant-treated RUPP rats attenuated this response. Impaired mitochondrial function and vascular, placental, and renal mitochondrial ROS play an important role in hypertension and reduced fetal weight in response to placental ischemia during pregnancy.

Entities:  

Keywords:  antioxidants; blood pressure; ischemia; mitochondria; reactive oxygen species

Mesh:

Substances:

Year:  2018        PMID: 30012871      PMCID: PMC6394841          DOI: 10.1161/HYPERTENSIONAHA.118.11290

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  45 in total

1.  Therapeutic targeting of mitochondrial superoxide in hypertension.

Authors:  Anna E Dikalova; Alfiya T Bikineyeva; Klaudia Budzyn; Rafal R Nazarewicz; Louise McCann; William Lewis; David G Harrison; Sergey I Dikalov
Journal:  Circ Res       Date:  2010-05-06       Impact factor: 17.367

2.  [Oxidative stress level and placental histological changes during preeclampsia].

Authors:  Juan Carlos Medrano Rodríguez; Patricia Yahuaca Mendoza; Manuel Presno Bernal; José Luis Alvarado Acosta
Journal:  Ginecol Obstet Mex       Date:  2008-06

3.  Proteomics analysis of human placenta reveals glutathione metabolism dysfunction as the underlying pathogenesis for preeclampsia.

Authors:  Xiaohan Jin; Zhongwei Xu; Jin Cao; Ping Shao; Maobin Zhou; Zhe Qin; Yan Liu; Fang Yu; Xin Zhou; Wenjie Ji; Wei Cai; Yongqiang Ma; Chengyan Wang; Nana Shan; Ning Yang; Xu Chen; Yuming Li
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2017-07-10       Impact factor: 3.036

4.  Expression of NADPH oxidase isoform 1 (Nox1) in human placenta: involvement in preeclampsia.

Authors:  X-L Cui; D Brockman; B Campos; L Myatt
Journal:  Placenta       Date:  2005-07-01       Impact factor: 3.481

5.  Decrease in cytochrome c oxidase activity detected cytochemically in the placental trophoblast of patients with pre-eclampsia.

Authors:  S Matsubara; H Minakami; I Sato; T Saito
Journal:  Placenta       Date:  1997-05       Impact factor: 3.481

6.  Nox2-induced production of mitochondrial superoxide in angiotensin II-mediated endothelial oxidative stress and hypertension.

Authors:  Sergey I Dikalov; Rafal R Nazarewicz; Alfiya Bikineyeva; Lula Hilenski; Bernard Lassègue; Kathy K Griendling; David G Harrison; Anna E Dikalova
Journal:  Antioxid Redox Signal       Date:  2013-10-30       Impact factor: 8.401

Review 7.  What we have learned about preeclampsia.

Authors:  Baha M Sibai; Steve Caritis; John Hauth
Journal:  Semin Perinatol       Date:  2003-06       Impact factor: 3.300

Review 8.  How mitochondria produce reactive oxygen species.

Authors:  Michael P Murphy
Journal:  Biochem J       Date:  2009-01-01       Impact factor: 3.857

Review 9.  Preeclampsia: long-term consequences for vascular health.

Authors:  Lorena M Amaral; Mark W Cunningham; Denise C Cornelius; Babbette LaMarca
Journal:  Vasc Health Risk Manag       Date:  2015-07-15

10.  Therapeutically targeting mitochondrial redox signalling alleviates endothelial dysfunction in preeclampsia.

Authors:  Cathal McCarthy; Louise C Kenny
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

View more
  40 in total

1.  Vascular endothelial mitochondrial oxidative stress in response to preeclampsia: a role for angiotension II type 1 autoantibodies.

Authors:  Evangeline Deer; V Ramana Vaka; Kristen M McMaster; Kedra Wallace; Denise C Cornelius; Lorena M Amaral; Mark W Cunningham; Babbette LaMarca
Journal:  Am J Obstet Gynecol MFM       Date:  2020-10-27

2.  Tumor necrosis factor alpha (TNF-α) blockade improves natural killer cell (NK) activation, hypertension, and mitochondrial oxidative stress in a preclinical rat model of preeclampsia.

Authors:  Mark W Cunningham; Aswathi Jayaram; Evangeline Deer; Lorena M Amaral; Venkata Ramana Vaka; Tarek Ibrahim; Denise C Cornelius; Babbette LaMarca
Journal:  Hypertens Pregnancy       Date:  2020-07-10       Impact factor: 2.108

3.  AP39, a Modulator of Mitochondrial Bioenergetics, Reduces Antiangiogenic Response and Oxidative Stress in Hypoxia-Exposed Trophoblasts: Relevance for Preeclampsia Pathogenesis.

Authors:  Ambart E Covarrubias; Edouard Lecarpentier; Agnes Lo; Saira Salahuddin; Kathryn J Gray; S Ananth Karumanchi; Zsuzsanna K Zsengellér
Journal:  Am J Pathol       Date:  2018-10-11       Impact factor: 4.307

4.  Blockade of endogenous angiotensin II type I receptor agonistic autoantibody activity improves mitochondrial reactive oxygen species and hypertension in a rat model of preeclampsia.

Authors:  Venkata Ramana Vaka; Mark W Cunningham; Evangeline Deer; Michael Franks; Tarek Ibrahim; Lorena M Amaral; Nathan Usry; Denise C Cornelius; Ralf Dechend; Gerd Wallukat; Babbette D LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-11-13       Impact factor: 3.619

Review 5.  Neurodevelopmental Outcomes of Prenatal Preeclampsia Exposure.

Authors:  Serena B Gumusoglu; Akanksha S S Chilukuri; Donna A Santillan; Mark K Santillan; Hanna E Stevens
Journal:  Trends Neurosci       Date:  2020-03-06       Impact factor: 13.837

Review 6.  Pre-eclampsia: pathogenesis, novel diagnostics and therapies.

Authors:  Elizabeth A Phipps; Ravi Thadhani; Thomas Benzing; S Ananth Karumanchi
Journal:  Nat Rev Nephrol       Date:  2019-05       Impact factor: 28.314

Review 7.  Renal Dopamine Receptors and Oxidative Stress: Role in Hypertension.

Authors:  Jian Yang; Van Anthony M Villar; Pedro A Jose; Chunyu Zeng
Journal:  Antioxid Redox Signal       Date:  2020-05-29       Impact factor: 8.401

8.  Placental Mitochondrial Abnormalities in Preeclampsia.

Authors:  Philippe Vangrieken; Salwan Al-Nasiry; Aalt Bast; Pieter A Leermakers; Christy B M Tulen; Paul M H Schiffers; Frederik J van Schooten; Alex H V Remels
Journal:  Reprod Sci       Date:  2021-02-01       Impact factor: 3.060

Review 9.  Hypoxia and the integrated stress response promote pulmonary hypertension and preeclampsia: Implications in drug development.

Authors:  Xiang-Qun Hu; Lubo Zhang
Journal:  Drug Discov Today       Date:  2021-07-22       Impact factor: 7.851

Review 10.  Oxidative Stress and Hypertension.

Authors:  Kathy K Griendling; Livia L Camargo; Francisco J Rios; Rhéure Alves-Lopes; Augusto C Montezano; Rhian M Touyz
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.